URL has been copied successfully!
Serina Therapeutics Inc. (NYSE:SER) jumped 39.45% in after-hours trading on Wednesday, climbing to $1.78, after the clinical-stage company announced a $15 million private placement closing on Friday.
Serina said in its Wednesday announcement, made after markets closed, that a second tranche of up to $15 million is expected by April 30, with warrant coverage potentially raising an additional $33.3 million.
CEO Steve Ledger noted that with the first patient dosed in the registrational trial and a clear 505(b)(2) pathway aligned with the Food and Drug Administration, the financing positions Serina to execute on its most value-creating milestones to date.
High-Profile Co-Chairman Strengthens Credibility
Serina’s transaction is led …
Please follow us:
